All products referenced on this site are for research purposes only. Not intended for human consumption. Read full disclaimer

GH Secretagogues

Research peptides studied for their effects on growth hormone secretion pathways in animal and in-vitro models.

Category Overview

Growth hormone secretagogues (GHS) are a category of research peptides that have been studied for their effects on the growth hormone axis, specifically their ability to stimulate growth hormone release through various receptor-mediated pathways. This is one of the most well-characterized categories in peptide research, with extensive literature on the mechanisms by which these compounds interact with the growth hormone secretagogue receptor (GHSR) and growth hormone releasing hormone receptor (GHRHR). Research in this area has applications in understanding growth hormone physiology, body composition regulation, metabolism, and age-related changes in GH secretion. Both Growth Hormone Releasing Hormones (GHRH analogs) and Growth Hormone Releasing Peptides (GHRPs) are included in this category, each working through distinct but complementary mechanisms.

Featured Research Peptides

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that binds to the ghrelin receptor (GHSR-1a). It has been studied for its selective GH release without significant effects on other pituitary hormones.

Research Areas

•Selective GH release mechanism studies
•Ghrelin receptor (GHSR-1a) binding research
•Bone density research in animal models
•Body composition studies
•Comparison studies with other GH secretagogues

CJC-1295 (no DAC)

CJC-1295 without Drug Affinity Complex (also known as Modified GRF 1-29) is a synthetic analog of growth hormone releasing hormone (GHRH). It stimulates GH release through the GHRH receptor pathway.

Research Areas

•GHRH receptor pathway activation
•Pulsatile GH release pattern studies
•Synergistic effects with GHRP compounds
•GH axis physiology research
•Metabolic effects in animal models

MK-677 (Ibutamoren)

MK-677 is an orally active growth hormone secretagogue that mimics the action of ghrelin. While technically not a peptide (it is a non-peptide compound), it is commonly grouped with GH secretagogues in research settings.

Research Areas

•Oral GH secretagogue mechanism studies
•Long-term GH elevation research
•Sleep quality and GH pulse studies
•Body composition research in animal models
•IGF-1 elevation mechanism studies

Research Highlights

1Ipamorelin was shown to selectively stimulate GH release without significant cortisol or prolactin elevation in animal studies
2CJC-1295 + Ipamorelin combination protocols are among the most studied GH secretagogue regimens in research
3MK-677 is the most studied oral GH secretagogue with Phase II clinical trial data available
4GH secretagogue research spans over 30 years with extensive published literature

Buying Considerations

✓GH secretagogue peptides should be verified for identity via Mass Spectrometry
✓Distinguish between CJC-1295 with DAC and without DAC (Mod GRF 1-29) as they have different properties
✓MK-677 is available in both capsule and liquid form from most vendors
✓Proper reconstitution and storage is critical for maintaining peptide activity